Relapsing diabetes can result from moderately activating mutations in KCNJ11

Human Molecular Genetics

Volumn 14, Issue 7, 2005, Pages 925-934

  Gloyn, Anna L ^a,b   Reimann, Frank ^c   Girard, Christophe ^b   Edghill, Emma L ^a   Proks, Peter ^b   Pearson, Ewan R ^a   Temple, I Karen ^d,e   Mackay, Deborah J G ^e,f   Shield, Julian P H ^g   Freedenberg, Debra ^h   Noyes, Kathryn ⁱ   Ellard, Sian ^a   Ashcroft, Frances M ^b   Gribble, Fiona M ^c   Hattersley, Andrew T ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NHS Trust   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^g BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^h TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

ⁱ ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

ANIMAL CELL; ARTICLE; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DISEASE SEVERITY; EPILEPSY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; HUMAN; IC 50; IN VITRO STUDY; INSULIN TREATMENT; MALE; MUTATIONAL ANALYSIS; NEWBORN; NEWBORN DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RELAPSE; REMISSION; SENSITIVITY ANALYSIS; WILD TYPE; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATE; ADULT; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 6; DIABETES MELLITUS; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; INHIBITORY CONCENTRATION 50; MALE; MODELS, MOLECULAR; MUTATION; OOCYTES; PEDIGREE; PHENOTYPE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RECEPTORS, DRUG; RECURRENCE; XENOPUS LAEVIS;

XENOPUS LAEVIS;

EID: 20244368494     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi086     Document Type: Article

References (40)

1. Shield, J.P. (2000) Neonatal diabetes: new insights into aetiology and implications. Horm. Res., 53 (Suppl. 1), 7-11.
2. Polak, M. and Shield, J. (2004) Neonatal and very-early-onset diabetes mellitus. Semin. Neonatol., 9, 59-65.
3. von Muhlendahl, K.E. and Herkenhoff, H. (1995) Long-term course of neonatal diabetes. N. Engl. J. Med., 333, 704-708.
4. Temple, I.K., Gardner, R.J., Mackay, D.J., Barber, J.C., Robinson, D.O. and Shield, J.P. (2000) Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes, 49, 1359-1366.
5. Temple, I.K., James, R.S., Crolla, J.A., Sitch, F.L., Jacobs, P.A., Howell, W.M., Betts, P., Baum, J.D. and Shield, J. (1995) An imprinted gene(s) for diabetes? Nat. Genet., 9, 110-112.
6. Gardner, R.J., Robinson, D.O., Lamont, L., Shield, J.P. and Temple, I.K. (1998) Paternal uniparental disomy of chromosome 6 and transient neonatal diabetes mellitus. Clin. Genet., 54, 522-525.
7. Temple, I.K., Gardner, R.J., Robinson, D.O., Kibirige, M.S., Ferguson, A.W., Baum, J.D., Barber, J.C.K., James, R.S. and Shield, J.P.H. (1996) Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23. Hum. Mol. Genet., 5 1117-1124.
8. Gardner, R.J., Mackay, D.J., Mungall, A.J., Polychronakos, C., Siebert, R., Shield, J.P., Temple, I.K. and Robinson, D.O. (2000) An imprinted locus associated with transient neonatal diabetes mellitus. Hum. Mol. Genet., 9, 589-596.
9. Kamiya, M., Judson, H., Okazaki, Y., Kusakabe, M., Muramatsu, M., Takada, S., Takagi, N., Arima, T., Wake, N., Kamimura, K. et al. (2000) The cell cycle control gene ZAC/PLAGL1 is imprinted - a strong candidate gene for transient neonatal diabetes. Hum. Mol. Genet., 9, 453-560.
10. Arima, T., Drewell, R.A., Oshimura, M., Wake, N. and Surani, M.A. (2000) A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC. Genomics, 67, 248-255.
11. Ma, D., Shield, J.P.H., Dean, W., Leclerc, I., Knauf, C., Burcelin, R., Rutter, G.A. and Kelsey, G. (2004) Imparied glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus (TNDM) locus. J. Clin. Invest., 114, 339-348.
12. Gloyn, A.L., Pearson, E.R., Antcliff, J.F., Proks, P., Bruining, G.J., Slingerland, A.S., Howard, N., Srinivasan, S., Silva, J.M., Molnes, J. et al. (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med., 350, 1838-1849.
13. Gloyn, A.L., Cummings, E.A., Edghill, E.L., Harries, L.W., Scott, R., Costa, T., Temple, I.K., Hattersley, A.T. and Ellard, S. (2004) Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel. J. Clin. Endocrinol. Metab., 89, 3932-3935.
14. Vaxillaire, M., Populaire, C., Buisiah, K., Cave, H., Gloyn, A.L., Hattersley A, T., Czernichow, P., Froguel, P. and Polak, M. (2004) Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes, 53, 2719-2722.
15. Sagen, J.V., Raeder, H., Hathout, E., Shehadeh, N., Gudmundsson, K., Baevre, H., Abuelo, D., Phornphutkul, C., Molnes, J., Bell, G. et al. (2004) Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapy. Diabetes, 53, 2713-2718.
16. Massa, O., Iafusco, D., D'Amato, E., Gloyn, A.L., Hattersley, A.T., Pasquino, B., Tonini, G., Dammacco, F., Zanette, G., Meschi, F. et al. (2005) KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum. Mutat., 25, 22-27.
17. Clement, J.P.I., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L. and Bryan, J. (1997) Association and stoichiometry of K-ATP channel subunits. Neuron, 18, 827-838.
18. Proks, P., Antcliff, J.F., Lippiat, J., Gloyn, A.L., Hattersley, A.T. and Ashcroft, F.M. (2004) Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc. Natl Acad. Sci. USA, 50, 17539-17544.
19. Gloyn, A.L., Weedon, M.N., Owen, K., Turner, M.J., Knight, B.A., Hitman, G.A., Walker, M., Levy, J.C., Sampson, M., Halford, S. et al. (2003) Large-scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 ABCC8) confirm that the KCNJ11 E23K variant is associated with Type 2 diabetes. Diabetes, 52, 568-572.
20. Nielsen, E.M., Hansen, L., Carstensen, B., Echwald, S.M., Drivsholm, T., Glumer, C., Thorsteinsson, B., Borch-Johnsen, K., Hansen, T. and Pedersen, O. (2003) The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes, 52, 573-577.
21. Love-Gregory, L., Wasson, J., Lin, J., Skolnick, G., Suarez, B. and Permutt, M.A. (2003) E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARgamma Pro12Ala variant. Diabetologia, 46, 136-137.
22. Florez, J., Burtt, N., de Bakker, P., Almgren, P., Tuomi, T., Holmkvist, J., Gaudet, D., Hudson, T., Schaffner, S., Daly, M. et al. (2004) Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes, 53, 1360-1368.
23. Riedel, M.J., Boora, P., Steckley, D., de Vries, G. and Light, P.E. (2003) Kir6.2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: a possible cellular mechanism for increased susceptibility to type 2 diabetes? Diabetes 52, 2630-2635.
24. Schwanstecher, C., Neugebauer, B., Schulz, M. and Schwanstecher, M. (2002) The common single nucleotide polymorphism E23K in K(IR)6.2 sensitizes pancreatic beta-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphates. Diabetes 51 (Suppl. 3), S363-S367.
25. Schwanstecher, C., Meyer, U. and Schwanstecher, M. (2002) K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes, 51, 875-879.
26. Thomas, P.M., Yuyang, Y. and Lightner, E. (1996) Mutation of the pancreatic islet inward rectifier, Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum. Mol. Genet. 5, 1809-1812.
27. Trapp, S., Haider, S., Jones, P., Sansom, M.S. and Ashcroft, F.M. (2003) Identification of residues contributing to the ATP binding site of Kir6.2. EMBO J., 22, 2903-2912.
28. Li, L., Wang, J. and Drain, P. (2000) The I182 region of k(ir)6.2 is closely associated with ligand binding in K(ATP) channel inhibition by ATP. Biophys. J., 79, 841-852.
29. Gribble, F.M., Tucker, S.J, Haug, T and Ashcroft, F.M. (1998) MgATP activates the beta-cell K-ATP channel by interaction with its SUR1 subunit. Proc. Natl Acad. Sci. USA, 95, 7185-7190.
30. Zung, A., Glaser, B., Nimri, R. and Zadik, Z. (2004) Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J. Clin. Endocrinol. Metab., 89 5504-5507.
31. Klupa, T., Warram, J.H., Antonellis, A., Pezzolesi, M., Nam, M., Malecki, M.T., Doria, A., Rich, S.S. and Krolewski, A.S. (2002) Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. Diabetes Care, 25, 2292-2301.
32. Bingham, C. and Hattersley, A.T. (2004) Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1(beta). Nephrol. Dial. Transplant., 19, 2703-2708.
33. Detimary, P., Dejonghe, S., Ling, Z., Pipeleers, D., Schuit, F. and Henquin, J.C. (1998) The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets. J. Biol. Chem., 273 33905-33908.
34. Seino, S., Iwanaga, T., Nagashima, K. and Miki, T. (2000) Diverse roles of K-ATP channels learned from Kir6.2 genetically engineered mice. Diabetes, 49, 311-318.
35. Koster, J.C., Marshall, B.A., Ensor, N., Corbett, J.A. and Nichols, C.G. (2000) Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell, 100, 645-654.
36. Frayling, T.M., McCarthy, M.I., Walker, M., Levy, J.C., O'Rahilly, S., Hitman, G.A., Rao, P.V., Bennett, A.J., Jones, E.C., Menzel, S. et al. (2000) No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians. J. Clin. Endocrinol. Metab., 85, 853-857.
37. + currents expressed in Xenopus oocytes. J. Physiol., 498, 87-98.
38. Trapp, S., Proks, P., Tucker, S.J. and Ashcroft, F.M. (1998) Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP. J. Gen. Physiol., 112, 333-349.
39. Kuo, A., Gulbis, J.M., Antcliff, J.F., Rahman, T., Lowe, E.D., Zimmer, J., Cuthbertson, J., Ashcroft, F.M., Ezaki, T. and Doyle, D.A. (2003) Crystal structure of the potassium channel KirBac1.1 in the closed state. Science, 300, 1922-1926.
40. Nishida, M. and MacKinnon, R. (2002) Structural basis of inward rectification: cytoplasmic pore of the G protein-gated inward rectifier GIRK1 at 1.8 A resolution. Cell, 111, 957-965.